anti-Trop2 AEC(Immunomedics)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug Nameanti-Trop2 AEC(Immunomedics)
Drug Alias NamehRS7-Rap AEC(Immunomedics)(Rap)₂-E1-(Rap)₂(Immunomedics)Trop-2-targeting tetrakis-ranpirnase(Immunomedics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-enzyme conjugates
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIbc Pharmaceuticals IncImmunomedics Inc
Active IndicationsN/A
Inactive IndicationsTriple Negative Breast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A